News
U.S. regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...
The U.S. Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...
The new test, known as the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, detects amyloid plaques through blood testing, a ...
A woman was arrested following a toxicology report of two fetuses that were found in a box in December 2024, according to ...
The first-ever blood test to detect Alzheimer’s disease has been cleared by the U.S. Food and Drug Administration (FDA). In a ...
FDA approves Lumipulse G, the first blood test that can help in the diagnosis of Alzheimer's disease. Read more here.
The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment ...
The FDA has cleared a new blood test that would significantly help in diagnosing patients with Alzheimer's disease. Unlike costly PET scans, this simple blood draw detects a key marker of Alzheimer’s.
The new test, from Fujirebio Diagnostics, Inc., identifies a sticky brain plaque, known as beta-amyloid, that is a key marker ...
The FDA has cleared the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio test, the first blood test for early Alzheimer's ...
Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...
The FDA cleared the first blood test on Friday to help diagnose Alzheimer's disease among older Americans already exhibiting signs and symptoms of the condition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results